Keurig Dr Pepper (KDP) Raised to Buy at Goldman Sachs Group

Goldman Sachs Group upgraded shares of Keurig Dr Pepper (NYSE:KDP) from a neutral rating to a buy rating in a report issued on Tuesday, Marketbeat reports. The brokerage currently has $26.35 target price on the stock.

KDP has been the subject of several other research reports. SunTrust Banks assumed coverage on shares of Keurig Dr Pepper in a research report on Friday, December 7th. They issued a buy rating and a $35.00 price objective for the company. Zacks Investment Research lowered shares of Keurig Dr Pepper from a buy rating to a hold rating in a report on Friday, November 16th. Morgan Stanley assumed coverage on shares of Keurig Dr Pepper in a report on Friday, December 21st. They set an equal weight rating and a $27.00 price target for the company. Citigroup raised their price target on shares of Keurig Dr Pepper from $26.00 to $30.00 and gave the company a hold rating in a report on Tuesday, November 13th. Finally, Gabelli lowered shares of Keurig Dr Pepper from a buy rating to a hold rating and set a $28.48 price target for the company. in a report on Thursday, November 8th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and six have given a buy rating to the company. The stock currently has a consensus rating of Hold and a consensus target price of $28.20.

KDP stock traded up $0.67 on Tuesday, hitting $26.95. 189,716 shares of the company were exchanged, compared to its average volume of 3,235,667. Keurig Dr Pepper has a twelve month low of $20.46 and a twelve month high of $126.65. The firm has a market capitalization of $37.23 billion, a price-to-earnings ratio of 5.94, a price-to-earnings-growth ratio of 1.25 and a beta of 0.52. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.28 and a current ratio of 0.40.

Keurig Dr Pepper (NYSE:KDP) last released its quarterly earnings data on Wednesday, November 7th. The company reported $0.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.02. Keurig Dr Pepper had a net margin of 13.55% and a return on equity of 15.76%. The company had revenue of $2.73 billion during the quarter, compared to analyst estimates of $2.87 billion. During the same quarter in the prior year, the business earned $0.21 earnings per share. The business’s quarterly revenue was up 139.6% compared to the same quarter last year. As a group, equities analysts forecast that Keurig Dr Pepper will post 1.04 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 18th. Investors of record on Friday, January 4th will be issued a dividend of $0.15 per share. The ex-dividend date is Thursday, January 3rd. This represents a $0.60 dividend on an annualized basis and a dividend yield of 2.23%. Keurig Dr Pepper’s dividend payout ratio is 13.22%.

In related news, Director Robert S. Singer purchased 5,000 shares of the firm’s stock in a transaction on Friday, November 9th. The shares were acquired at an average cost of $28.35 per share, with a total value of $141,750.00. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Brian Andrew Loucks purchased 17,500 shares of the firm’s stock in a transaction on Monday, December 10th. The stock was bought at an average cost of $26.00 per share, for a total transaction of $455,000.00. The disclosure for this purchase can be found here. Over the last three months, insiders have purchased 62,830 shares of company stock worth $1,679,828. 0.58% of the stock is currently owned by insiders.

Institutional investors have recently made changes to their positions in the business. Marshall Wace LLP bought a new stake in Keurig Dr Pepper during the second quarter valued at about $3,746,000. Public Employees Retirement System of Ohio bought a new position in Keurig Dr Pepper during the second quarter valued at approximately $8,695,000. Bath Savings Trust Co purchased a new position in shares of Keurig Dr Pepper in the 3rd quarter valued at about $409,000. Cerebellum GP LLC purchased a new position in shares of Keurig Dr Pepper in the 3rd quarter valued at about $188,000. Finally, State of Alaska Department of Revenue purchased a new position in shares of Keurig Dr Pepper in the 3rd quarter valued at about $17,663,000. 10.77% of the stock is currently owned by institutional investors and hedge funds.

Keurig Dr Pepper Company Profile

Keurig Dr Pepper Inc engages in the brewing system and specialty coffee businesses in the United States and Canada. The company sources, produces, and sells coffee, hot cocoa, teas, and other beverages in K-Cup, Vue, Rivo, K-Carafe, and K-Mug pods brands; coffee in traditional packaging, including bags and fractional packs; and other specialty beverages in pods.

Read More: Cost of Equity

Analyst Recommendations for Keurig Dr Pepper (NYSE:KDP)

Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply